⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
$16.8 Billion Targeted Cancer Therapy Market Report 2026-2031: Revenue to Grow by Nearly $10 Billion Over the Forecast Period
globenewswire.com
NVS
GSK
NVDA
LLY
Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine
prnewswire.com
GOOGL
JNJ
LLY
NVS
Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases
globenewswire.com
NVS
ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers
prnewswire.com
JNJ
PFE
NVS
AI Transforms Pharmaceutical Packaging as Industry Invests Billions in Zero-Defect Quality Control Systems
globenewswire.com
NVS
PFE
JNJ
Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape | DelveInsight
globenewswire.com
ABBV
NVS
ALC
JNJ
BHC
Pharmaceutical Packaging Essentials 3-Day Training Course: From Regulatory Compliance to Market Success (Online: Sept 22nd-Sept 24th, 2026)
globenewswire.com
GSK
NVS
Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
globenewswire.com
NVS
PFE
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
globenewswire.com
NVS
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
globenewswire.com
NVS